[ad_1]

Capital Blue Cross is the first health insurer to partner with Mark Cuban’s Cost Plus Drug Co., which sells prescription medicines at fixed-rate markups, the companies announced Thursday.

Capital Blue Cross will begin covering members’ purchases at Cost Plus Drugs next year.

“Capital’s collaboration with Cost Plus Drugs will help us bring lower-cost medications to members and non-members alike across our service area, providing some much-needed relief to those struggling to pay for their vital—and sometimes lifesaving—medications,” Capital Blue Cross president and CEO Todd Shamash said in a news release. The Blue Cross and Blue Shield carrier operates in central Pennsylvania.

The not-for-profit health insurer’s partnership is an “anomaly,” said Antonio Ciaccia, president of 3 Axis Advisors, who has previously done data analytics work for Cuban’s company. “Most health plans are using traditional pharmacy benefit managers who are responsible for creating this culture of high prices in the first place because of the incentives,” he said.

Billionaire Cuban’s for-profit drug company sells medicines for 15% more than it pays manufacturers. Cost Plus Drugs launched an online pharmacy in January that offers 1,000 prescription drugs, including cholesterol medication atorvastatin, also known as Lipitor, which costs about $4 per month through the company.

Blue Cross and Blue Shield plans are typically more aligned with the interests of plan sponsors than are for-profit insurance companies, Ciaccia said. More health insurance companies and pharmacy benefit managers will team up with Cost Plus Drugs over time, he predicted.

[ad_2]

Source link

Leave a Reply

Explore More

Health system’s second-quarter financials mixed

[ad_1] Labor costs, driven by demand for contract workers amid staff shortages, were the hot topic in the hospital industry’s second-quarter earnings reports. Health system are doling out higher pay

CDC urges Pfizer booster for children ages 5 to 11

[ad_1] Kids ages 5 to 11 should get a booster dose of Pfizer’s COVID-19 vaccine, advisers to the US government said Thursday. The Center for Disease Control and Prevention quickly

US chemotherapy shortage leading to cancer treatment complications

[ad_1] A growing shortage of common cancer treatments is forcing doctors to switch medications and delay some care, prominent US cancer centers say. The National Comprehensive Cancer Network said Wednesday